C4 Therapeutics
Vincent Chu is a Research Scientist at C4 Therapeutics, Inc. with a background in Chemistry and Chemical Biology. Previously, they have conducted research at prestigious institutions such as Harvard Medical School, Princeton University, and The University of Melbourne. Vincent's work has focused on protein degradation pathways, cellular assays, molecular cloning, and biochemical assays. Their experience also includes investigating the role of 1-methylnicotinamide on adipocyte metabolism and synthesizing quantum dots for biolabeling applications.
This person is not in the org chart
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.